# Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

> **NCT03602781** · PHASE3 · WITHDRAWN · sponsor: **Bellerophon Pulse Technologies**

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Placebo
- **DRUG:** iNO

## Key facts

- **NCT ID:** NCT03602781
- **Lead sponsor:** Bellerophon Pulse Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decision not to proceed with Study
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602781, "Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03602781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*